Product-specific advice (steroid nasal sprays) [Design Issues]

posted by Mikalai  – Belarus, 2018-10-16 11:42 (774 d 15:58 ago) – Posting: # 19451
Views: 2,133

(edited by Mikalai on 2018-10-16 13:35)

Dear friends,
Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids? More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.

Complete thread:

 Admin contact
21,216 posts in 4,427 threads, 1,481 registered users;
online 13 (0 registered, 13 guests [including 8 identified bots]).
Forum time: Sunday 03:40 UTC (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz